183 related articles for article (PubMed ID: 3117719)
1. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
Nagata M; Robison WG
Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
[TBL] [Abstract][Full Text] [Related]
2. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase and retinal capillary basement membrane thickening.
Robison WG; Nagata M; Kinoshita JH
Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
[TBL] [Abstract][Full Text] [Related]
5. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
Robison WG; Kador PF; Akagi Y; Kinoshita JH; Gonzalez R; Dvornik D
Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
[TBL] [Abstract][Full Text] [Related]
6. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
Robison WG; Tillis TN; Laver N; Kinoshita JH
Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
[TBL] [Abstract][Full Text] [Related]
7. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
[TBL] [Abstract][Full Text] [Related]
8. The polyol pathway in retinal microangiopathy.
Robison WG; Kinoshita JH; Kador PF
Drugs; 1986; 32 Suppl 2():19-22. PubMed ID: 3098542
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase activity and basement membrane thickening.
Frank RN
Metabolism; 1986 Apr; 35(4 Suppl 1):35-40. PubMed ID: 3083207
[TBL] [Abstract][Full Text] [Related]
10. A new approach against sugar cataract through aldose reductase inhibitors.
Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
[TBL] [Abstract][Full Text] [Related]
11. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
Das A; Frank RN; Zhang NL; Samadani E
Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
[TBL] [Abstract][Full Text] [Related]
12. Galactose-induced retinal microangiopathy in rats.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
[TBL] [Abstract][Full Text] [Related]
13. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
14. Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.
Frank RN; Keirn RJ; Kennedy A; Frank KW
Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1519-24. PubMed ID: 6642931
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
Robison WG; Laver NM; Jacot JL; Chandler ML; York BM; Glover JP
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1066-73. PubMed ID: 9152226
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
17. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
Terubayashi H; Akagi Y
Jpn J Ophthalmol; 1989; 33(3):343-7. PubMed ID: 2507812
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor Tolrestat.
Calcutt NA; McMurray HF; Moorhouse DF; Bache M; Parthasarathy S; Powell HC; Mizisin AP
Exp Neurol; 1994 Aug; 128(2):226-32. PubMed ID: 8076666
[TBL] [Abstract][Full Text] [Related]
19. Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.
McCaleb ML; McKean ML; Hohman TC; Laver N; Robison WG
Diabetologia; 1991 Oct; 34(10):695-701. PubMed ID: 1959701
[TBL] [Abstract][Full Text] [Related]
20. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats.
Chakrabarti S; Sima AA
Diabetes; 1989 Sep; 38(9):1181-6. PubMed ID: 2504638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
